Pharmachem Innovations

What Pharmachem Innovations does

Pharmachem Innovations is a B2B nutraceutical ingredients company that develops, manufactures, and supplies proprietary branded specialty ingredients, delivery systems, and custom formulation services to nutritional product companies, contract manufacturing organizations (CMOs), and MLM/fulfillment/direct-to-consumer supplement brands. Its core product portfolio is anchored by clinically supported branded ingredients—Phase 2™ Carb Controller (white kidney bean extract, 14+ human studies), GPM™ Fermented Nutrients (glycoprotein-matrix fermented vitamins and minerals), Prenulin™ Blend (blood sugar management), Perluxan™ (hops extract for joint health), and Cran-Max™ (whole-fruit cranberry concentrate with FDA-qualified health claims). These branded ingredients sit on top of proprietary delivery and processing platforms including Acti-Solve™ particle engineering, Bio-Shield™ encapsulation, Nutrapress™ BND and CHW organic tablet binders, and StableFizz™ effervescent granulation, with distribution partnerships extending the catalog into Probiotical® probiotics (Italy) and Waitaki Biosciences® ingredients (New Zealand).

The business operates three revenue streams: (1) proprietary branded ingredient sales (licensing/royalty-like economics on ingredients sold to brands), (2) custom formulation and contract/toll manufacturing services, and (3) private label and market-ready pre-blended products. Pricing is quote-based B2B and not publicly disclosed. The company is headquartered in Kearny, New Jersey, with manufacturing facilities in New Jersey, Utah, and Tamaulipas, Mexico, and reaches customers in 70+ countries. Following its August 2024 acquisition from Ashland Inc. by Turnspire Capital Partners, Pharmachem launched as an independent company on September 3, 2024, with Árpád Széchényi joining as President and CEO in May 2025.

Name

Pharmachem Innovations

Legal name

Pharmachem Laboratories, LLC

Website

https://pharmachem.com

Company type

Private

Founded year

1972

Operating status

Operating

Headcount range

251–500 employees

Short description

Pharmachem Innovations is a B2B nutraceutical ingredients company that develops proprietary branded ingredients, delivery systems, and contract manufacturing services for nutritional product companies, CMOs, and DTC supplement brands in 70+ countries.

Ownership category

akta.pro rank

Product category

Nutraceutical Ingredients

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411), Drugs and Druggists' Sundries Merchant Wholesalers (4242)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)

Keywords

• Nutraceutical ingredients
• Contract manufacturing
• Branded specialty ingredients
• Custom formulation services
• Dietary supplement ingredients

Headquarters

HQ city

Kearny

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Proprietary Branded Ingredients: Revenue from proprietary branded ingredients including Phase 2™ Carb Controller, GPM™ fermented nutrients, and other specialty ingredients sold to nutritional product companies
2. Custom Formulation and Manufacturing Services: Contract manufacturing and custom formulation services for brands and CMOs
3. Private Label Products: Private label manufacturing of nutritional supplements and ingredients

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Pharmachem Innovations develops and manufactures proprietary branded nutraceutical ingredients (such as Phase 2 Carb Controller, GPM Fermented Nutrients, and Cran-Max) and provides custom formulation and contract/toll manufacturing services to nutritional product companies, CMOs, and MLM/DTC brands. The company operates manufacturing facilities in New Jersey, Utah, and Tamaulipas, Mexico, and distributes its ingredient portfolio to customers in more than 70 countries.

Product overview

Pharmachem Innovations is a B2B nutraceuticals ingredients company offering a portfolio of branded specialty ingredients, proprietary delivery systems, and custom manufacturing services. The core branded ingredient portfolio includes five flagship products: Phase 2™ Carb Controller (white kidney bean extract for weight management), GPM™ Fermented Nutrients (fermented vitamins/minerals platform with improved bioavailability), Prenulin™ Blend (blood sugar management), Perluxan™ Hops Extract (joint health), and Cran-Max™ Cranberry Concentrate (urinary tract health). Supporting these are proprietary delivery systems including Nutrapress™ BND (organic tablet binder), Nutrapress™ CHW (organic chewable base), and StableFizz™ effervescent granulation, plus the Acti-Solve™ particle engineering platform for ingredient optimization. The company also distributes performance ingredients including Probiotical® probiotics from Italy, Waitaki Biosciences® ingredients from New Zealand, and NordicCherry® tart cherry extract. Services include custom formulation, contract/toll manufacturing, and market-ready pre-blended solutions for faster commercialization.

Differentiator

Problem solved

Functional benefit

Brands

• Phase 2™ Carb Controller: Proprietary white kidney bean extract for weight management, clinically studied to reduce starch absorption by up to 66%.
• GPM™ Fermented Nutrients
• Prenulin™ Blend
• Perluxan™ Hops Extract
• Cran-Max™ Cranberry Concentrate
• Nutrapress™ BND
• Nutrapress™ CHW
• Probiotical® Probiotics
• Waitaki® Biosciences
• Acti-Solve™
• StableFizz™

Products and services

• Phase 2 Carb Controller

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Probiotical S.p.A.coreStrategic or Co-development PartnerItalian manufacturer of probiotics that Pharmachem distributes in North America. This strategic partnership extends Pharmachem's portfolio into the probiotics category, leveraging their distribution network and customer relationships.
• Waitaki BiosciencescoreChannel Partner/ Reseller/ DistributorNew Zealand company whose ingredients Pharmachem distributes, expanding their geographic reach and ingredient portfolio with New Zealand-sourced specialty ingredients.
• Ashland Inc. (NYSE: ASH)minorOthersPrevious owner of the Pharmachem business prior to acquisition by Turnspire Capital Partners in August 2024. Ashland sold the business as part of their portfolio optimization strategy.

Scale indicators3 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• DSM-Firmenich: Global ingredients giant with a deep health, nutrition and care portfolio (vitamins, premixes, HMOs, omega-3) — competes with Pharmachem across multiple categories and has the scale and R&D budget to outpace smaller specialty players.
• Cargill Health & Nutrition: Cargill's health ingredients and contract manufacturing arm (including the former Provimi and Diamond V premix businesses) supplies nutritional brands globally — a broad incumbent with overlapping CDMO and specialty ingredient capabilities.
• ADM Health & Wellness: Archer Daniels Midland's Health & Wellness segment offers flavors, colors, and functional ingredients for supplements and functional foods — broad portfolio competitor with global reach that overlaps with Pharmachem's custom formulation and branded ingredient lines.
• Lonza Capsules & Health Ingredients: Division of Lonza Group supplying capsules, particle engineering, and specialty health ingredients globally — adjacent technology overlap (notably particle engineering, similar to Acti-Solve) and a direct competitor for CDMO and specialty ingredient contracts.

Direct peers

• Glanbia Nutritionals: Global B2B supplier of premix solutions, specialty proteins, and ingredient systems for the nutrition and supplement industry, combining proprietary ingredients with custom formulation/contract manufacturing — overlapping with Pharmachem's three-pillar model.
• Sabinsa Corporation: Privately held US-headquartered manufacturer of patented, clinically validated branded nutraceutical ingredients (Curcumin C3 Complex, BioPerine, etc.) sold to global supplement brands — a near-direct analog to Pharmachem's Phase 2/GPM/Perluxan model.
• Indena SpA: Italian manufacturer of high-purity botanical extracts and active pharmaceutical ingredients with a branded portfolio (e.g., Meriva, Quercefit) sold globally to nutraceutical and pharma customers — directly comparable botanical ingredient business.
• Gnosis by Lesaffre: Business unit of Lesaffre focused on human nutrition ingredients including probiotics, yeasts, and vitamins, with proprietary branded technologies (e.g., Lynside, LifeinU) — overlapping directly with Pharmachem's GPM and Probiotical franchises.
• PLT Health Solutions: US-based B2B ingredient platform offering a portfolio of proprietary branded nutraceutical ingredients backed by clinical research, distributed globally to supplement and functional food brands — closely comparable branded ingredients business model.
• Kemin Industries: Privately held global ingredient manufacturer with proprietary, science-backed branded ingredients in human nutrition (and animal nutrition), serving similar B2B brand customers and contract manufacturing partners.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Pharmachem_
• Facebookfacebook.com/61563389706561
• LinkedInlinkedin.com/company/pharmachem-innovations
• Instagraminstagram.com/pharmachem_innovations

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmachem Innovations